drug approval pathways

Fast Track and Breakthrough Therapy designations represent two of the most strategically important expedited pathways within the US drug development framework, both administered by the Food and Drug Administration. While they share a common objective of accelerating therapies for serious conditions, their evidentiary thresholds, regulatory privileges, and commercialisation implications differ in ways that directly impact … Read more